Abstract
Renal tubular epithelial-mesenchymal transition (EMT) is one of the original steps of renal interstitial fibrosis in diabetic nephropathy (DN). Transforming growth factor-β1 (TGF-β1) is the leading inducer of EMT. Understanding the developing process of EMT in the renal tubular epithelium of DN and investigating the therapeutic usages of Smad7, C-peptide, TGF-β1 antibodies, histone deacetylase inhibitors, and angiotensin receptor antagonists in DN will provide new strategies for the treatment of DN. Key words: Diabetic nephropathy; EMT; Interstitial fibrosis; TGF-β1
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
